Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2012
03/28/2012CN101638426B New preparation method for triptolide
03/28/2012CN101325880B Oral tolerance promotion with glycated proteins
03/28/2012CN101270379B Preparation method for abstracting collagen helical peptide from wood frog tissue
03/28/2012CN101125836B Costene lactone derivative and medical use thereof
03/28/2012CN101035563B Multimeric VLA-4 antagonists comprising polymer moieties
03/27/2012US8143385 Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor
03/27/2012US8143261 Thiazolo (4,5-D) pyrimidine compounds
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012CA2540541C Alkoxy substituted imidazoquinolines
03/27/2012CA2528007C Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
03/27/2012CA2494796C Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2362964C Fucosyl transferase gene
03/22/2012WO2012037562A2 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012WO2012036214A1 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants
03/22/2012WO2012036152A1 High purity heparin and production method therefor
03/22/2012WO2012035364A1 Stabilized solution of ortho-silicic acid, its preparation and use
03/22/2012WO2012034498A1 Product of functional health food that enhances organ immunity
03/22/2012WO2012034203A1 Attenuated strain of corynebacterium pseudotuberculosis and live vaccine against caseous lymphadenite
03/22/2012WO2012034188A1 Peptide inhibitors of cd40l signaling and uses therefor
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071556 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012US20120071555 Compositions of abscisic acid for animal health
03/22/2012US20120071550 Synergistic combinations of cartonoids and polyphenols
03/22/2012US20120071547 Compounds from soft coral, method of preparation and pharmaceutical uses thereof
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071509 process
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071494 Pyrazolopyridine kinase inhibitors
03/22/2012US20120071479 Pyrazine derivatives as enac blockers
03/22/2012US20120071473 Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
03/22/2012US20120071463 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071449 Pharmaceutical composition for inhalation
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071433 Substituted 6-(Benzylamino) Purine Riboside Derivatives, Use Thereof and Compositions Containing These Derivatives
03/22/2012US20120071395 TREATMENT OF MAMMALIAN PHYSIOLOGICAL REACTION OF IgE ANTIBODIES PRESENT IN SAID MAMMAL UPON CONTACT WITH THE CORRESPONDEING ANTIGEN
03/22/2012US20120070512 Substituted 6-(2-hydroxybenzylamino)purine Derivatives, Their Use as Medicaments and Compositions Containing These Derivatives
03/22/2012US20120070493 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/22/2012US20120070491 Casb7439 constructs
03/22/2012US20120070488 Method of inducing neutralizing antibodies to human immunodeficiency virus
03/22/2012US20120070464 Monoparamunity inducers based on attenuated rabbit myxomaviruses
03/22/2012US20120070463 Method of biotechnological production fo bovine hemoderivative and use of bovine hemoderivative
03/22/2012US20120070462 Targeted Gene Delivery to Dendritic Cells
03/22/2012US20120070461 Use of myeloid cell biomarkers for the diagnosis of cancer
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070453 Methods for Preparing and Delivering Adjuvant Compositions
03/22/2012US20120070452 Immunoadjuvant composition and use thereof
03/22/2012US20120070449 Methods of treating inflammation
03/22/2012US20120070441 Extracellular yaluronidase from streptomyces koganeiensis
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070416 Macrocyclic Proline Derived HCV Serine Protease Inhibitors
03/22/2012US20120070412 HCV Inhibitor and Therapeutic Agent Combinations
03/22/2012US20120070410 Imidazolothiazole compounds and methods of use thereof
03/22/2012US20120070408 Methods and compositions for treating lupus
03/22/2012US20120070401 Composition and Method for Promoting Wound Healing
03/22/2012US20120070390 Topical drug delivery system with dual carriers
03/22/2012US20120070372 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
03/22/2012US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
03/22/2012CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012CA2811186A1 High purity heparin and production method therefor
03/22/2012CA2809641A1 Pharmaceutical and nutraceutical compositions of abscisic acid
03/21/2012EP2431371A1 Thiophene derivatives
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2429577A2 New human rotavirus strains and vaccines
03/21/2012EP2429566A2 Cyclin dependent kinase inhibitors and methods of use
03/21/2012EP2429560A1 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
03/21/2012EP2429557A2 Infant feeding formulas comprising probiotic micro-organisms
03/21/2012EP2429556A2 Growing up milks containing probiotic micro-organisms
03/21/2012EP2429554A1 Probiotic containing modules for tube feeding
03/21/2012EP2429553A1 Complete liquid nutrition for children at the age of 1-10 years comprising probiotics
03/21/2012EP2429552A1 Oral nutritional supplement comprising probiotics
03/21/2012EP2429551A1 Dry whole milk preparations containing probiotic micro-organisms
03/21/2012EP2429550A1 Nutritionally balanced standard tube feeding formula containing probiotics
03/21/2012EP2429549A1 Breakfast cereals containing probiotic micro organisms
03/21/2012EP2429548A1 Oral nutritional supplement for children comprising probiotics
03/21/2012EP2429547A1 Non-replicating micro-organisms and their immune boosting effect
03/21/2012EP2429546A1 Infant cereal comprising non-replicating probiotic microorganisms
03/21/2012EP2429543A1 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics
03/21/2012EP2429542A1 Prevention and treatment of allergic diarrhoea
03/21/2012EP2429541A1 Specialized medical nutrition for surgical and trauma patients containing probiotics
03/21/2012EP2429540A1 Infant and young children feeding formula comprising probiotics for infants and young children
03/21/2012EP2429539A1 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS
03/21/2012EP2429538A1 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
03/21/2012EP2429534A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix
03/21/2012EP2429533A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity
03/21/2012EP2325169A9 Lisofylline analogues and their pharmeacuetical uses
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
03/21/2012EP2074147B1 Antibodies against ccr5 and uses thereof
03/21/2012EP2018869B1 Licorice polyphenol preparation
03/21/2012EP1771155B1 Method and composition for treating rhinitis
03/21/2012EP1506409B1 Assays for modulators of asparaginyl hydroxylase
03/21/2012EP1313853B1 Modulation of fas and fasl expression by a synthetic phosphodiester oligonucleotide and an anti-fas antibody
03/21/2012CN1922148B Pyrazole derivatives as protein kinase modulators
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN102388139A Modulation of toll-like receptor 5 expression by antisense oligonucleotides
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 1172